Glycolytic heterogeneity drives metabolic-targeted therapy in pancreatic ductal adenocarcinoma.
胰腺导管腺癌的代谢靶向治疗依赖于糖酵解异质性。
期刊:Signal Transduction and Targeted Therapy
影响因子:52.7
doi:10.1038/s41392-025-02546-8
Chianese Ugo, Papulino Chiara, Saggese Gerardo, Ali Ahmad, Ciotola Marianna, Lonardo Enza, Cortese Mirko, Favale Gregorio, Di Mauro Annabella, La Gioia Danila, Golino Valentina, Sommella Eduardo, Campiglia Pietro, Franco Renato, Ciardiello Fortunato, De Vita Ferdinando, Carafa Vincenzo, Altucci Lucia, Benedetti Rosaria